DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,031,744 | -25.0% | 316,961 | -17.0% | 0.00% | -20.0% |
| Q2 2023 | $5,375,913 | -56.0% | 381,812 | -51.7% | 0.01% | -61.5% |
| Q1 2023 | $12,217,644 | -25.3% | 790,786 | -20.8% | 0.01% | -27.8% |
| Q4 2022 | $16,365,300 | +11.9% | 998,493 | +26.3% | 0.02% | +5.9% |
| Q3 2022 | $14,623,000 | +566.2% | 790,411 | +373.6% | 0.02% | +466.7% |
| Q2 2022 | $2,195,000 | +270.8% | 166,885 | +161.2% | 0.00% | +200.0% |
| Q1 2022 | $592,000 | -59.6% | 63,894 | -57.4% | 0.00% | 0.0% |
| Q4 2021 | $1,465,000 | +330.9% | 149,908 | +1399.1% | 0.00% | – |
| Q3 2021 | $340,000 | -7.1% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $366,000 | -18.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2021 | $448,000 | -70.9% | 10,000 | -62.9% | 0.00% | -100.0% |
| Q4 2020 | $1,538,000 | -3.3% | 26,943 | -13.1% | 0.00% | -33.3% |
| Q3 2020 | $1,591,000 | -14.1% | 31,022 | -0.0% | 0.00% | +50.0% |
| Q2 2020 | $1,853,000 | +349.8% | 31,025 | +210.2% | 0.00% | +100.0% |
| Q1 2020 | $412,000 | -50.4% | 10,000 | -25.1% | 0.00% | 0.0% |
| Q4 2019 | $831,000 | -35.0% | 13,351 | -64.6% | 0.00% | -50.0% |
| Q3 2019 | $1,279,000 | +252.3% | 37,689 | +308.3% | 0.00% | – |
| Q2 2018 | $363,000 | – | 9,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |